Literature DB >> 24375220

A randomised trial of oral versus intravenous opioids for treatment of pain after cardiac surgery.

Kurt Ruetzler1, Constance J Blome, Sabine Nabecker, Natalya Makarova, Henrik Fischer, Harald Rinoesl, Georg Goliasch, Daniel I Sessler, Herbert Koinig.   

Abstract

BACKGROUND: Cardiac surgery and sternotomy are procedures accompanied by substantial postoperative pain which is challenging to treat. In general, intravenous (IV) opioids are used in the immediate postoperative phase, followed by oral opioids. Oral opioids are easier to use and generally less expensive. Our goal was thus to determine whether a new opioid preparation provides adequate analgesia after sternotomy. In particular, we tested the primary hypothesis that total opioid use (in morphine equivalents) is not greater with oral opioid compared with patient-controlled IV morphine. Our secondary hypothesis was that analgesic efficacy is similar with oral and IV opioids.
METHODS: A total of 51 patients having elective cardiac surgery were enrolled in this study. After rapid postoperative respiratory weaning, the patients were randomised into one of two groups receiving different types of analgesia: oral Targin (a combination of oxycodone-hydrochloride and the opioid antagonist naloxone hydrochloride-dihydrate) or patient-controlled IV morphine. Pain score (visual analogue scale), sedation (Ramsey score), respiratory rate and side effects were assessed at 3, 5, 7, 9 and 11 h after surgery, and every 6 h throughout the third postoperative evening.
RESULTS: The total opioid dose in morphine equivalent doses was significantly lower with oral opioid than with IV morphine (adjusted geometric means [95 % confidence interval]: 34 [29; 38] vs. 69 [61; 78] mg, respectively). Pain scores were similar in each group.
CONCLUSIONS: Analgesic quality was comparable with oral and IV opioids, suggesting that postoperative pain even after very painful procedures can be sufficiently managed with oral opioids.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24375220     DOI: 10.1007/s00540-013-1770-x

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  14 in total

Review 1.  Treatment of acute postoperative pain.

Authors:  Christopher L Wu; Srinivasa N Raja
Journal:  Lancet       Date:  2011-06-25       Impact factor: 79.321

2.  Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study.

Authors:  Robert Buynak; Douglas Y Shapiro; Akiko Okamoto; Ilse Van Hove; Christine Rauschkolb; Achim Steup; Bernd Lange; Claudia Lange; Mila Etropolski
Journal:  Expert Opin Pharmacother       Date:  2010-08       Impact factor: 3.889

3.  Does coronary artery bypass surgery affect metoprolol bioavailability.

Authors:  Antti Valtola; Hannu Kokki; Merja Gergov; Ilkka Ojanperä; Veli-Pekka Ranta; Tapio Hakala
Journal:  Eur J Clin Pharmacol       Date:  2007-02-28       Impact factor: 2.953

Review 4.  Oxycodone for the treatment of postoperative pain.

Authors:  Hannu Kokki; Merja Kokki; Sari Sjövall
Journal:  Expert Opin Pharmacother       Date:  2012-05       Impact factor: 3.889

5.  Controlled sedation with alphaxalone-alphadolone.

Authors:  M A Ramsay; T M Savege; B R Simpson; R Goodwin
Journal:  Br Med J       Date:  1974-06-22

6.  A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.

Authors:  Winfried Meissner; Petra Leyendecker; Stefan Mueller-Lissner; Joachim Nadstawek; Michael Hopp; Christian Ruckes; Stefan Wirz; Wolfgang Fleischer; Karen Reimer
Journal:  Eur J Pain       Date:  2008-08-31       Impact factor: 3.931

7.  Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.

Authors:  Dana Vondrackova; Petra Leyendecker; Winfried Meissner; Michael Hopp; Istvan Szombati; Kai Hermanns; Christian Ruckes; Susanne Weber; Birgit Grothe; Wolfgang Fleischer; Karen Reimer
Journal:  J Pain       Date:  2008-08-16       Impact factor: 5.820

8.  Conversion to oral controlled-release oxycodone from intravenous opioid analgesic in the postoperative setting.

Authors:  Brian Ginsberg; Raymond S Sinatra; Lauri J Adler; James C Crews; Allen H Hord; Charles E Laurito; Michael A Ashburn
Journal:  Pain Med       Date:  2003-03       Impact factor: 3.750

9.  Opioid equianalgesic tables: are they all equally dangerous?

Authors:  Philip E Shaheen; Declan Walsh; Wael Lasheen; Mellar P Davis; Ruth L Lagman
Journal:  J Pain Symptom Manage       Date:  2009-09       Impact factor: 3.612

10.  Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain.

Authors:  K Simpson; P Leyendecker; M Hopp; S Müller-Lissner; O Löwenstein; J De Andrés; J Troy Ferrarons; B Bosse; B Krain; T Nichols; W Kremers; K Reimer
Journal:  Curr Med Res Opin       Date:  2008-12       Impact factor: 2.580

View more
  2 in total

1.  Perioperative Pain Management Issues Unique to Older Adults Undergoing Surgery: A Narrative Review.

Authors:  Adam D Shellito; Jill Q Dworsky; Patrick J Kirkland; Ronnie A Rosenthal; Catherine A Sarkisian; Clifford Y Ko; Marcia M Russell
Journal:  Ann Surg Open       Date:  2021-09

2.  Bioavailability of oxycodone by mouth in coronary artery bypass surgery patients - a randomized trial.

Authors:  Antti Valtola; James D Morse; Pawel Florkiewicz; Heidi Hautajärvi; Pasi Lahtinen; Tadeusz Musialowicz; Brian J Anderson; Veli-Pekka Ranta; Hannu Kokki
Journal:  J Drug Assess       Date:  2020-07-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.